An Open-label Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment
Latest Information Update: 22 Jan 2026
At a glance
- Drugs TS-172 (Primary)
- Indications Hyperphosphataemia
- Focus Pharmacokinetics
- Sponsors Taisho Pharmaceutical
Most Recent Events
- 05 Dec 2025 Planned initiation date (estimated date for recruitment of the first subject) changed from 1 Nov 2025 to 1 Dec 2025.
- 05 Dec 2025 Status changed from not yet recruiting to recruiting.
- 25 Nov 2025 New trial record